RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Floyd L. Wormley Jr. to Cryptococcosis

This is a "connection" page, showing publications Floyd L. Wormley Jr. has written about Cryptococcosis.
Connection Strength

8.172
  1. Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Mueller M, Wormley FL. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans. Infect Immun. 2015 Dec; 83(12):4513-27.
    View in: PubMed
    Score: 0.511
  2. Leopold Wager CM, Wormley FL. Is Development of a Vaccine against Cryptococcus neoformans Feasible? PLoS Pathog. 2015 Jun; 11(6):e1004843.
    View in: PubMed
    Score: 0.504
  3. Leopold Wager CM, Hole CR, Wozniak KL, Olszewski MA, Wormley FL. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice. J Immunol. 2014 Oct 15; 193(8):4060-71.
    View in: PubMed
    Score: 0.477
  4. Chaturvedi AK, Hameed RS, Wozniak KL, Hole CR, Leopold Wager CM, Weintraub ST, Lopez-Ribot JL, Wormley FL. Vaccine-mediated immune responses to experimental pulmonary Cryptococcus gattii infection in mice. PLoS One. 2014; 9(8):e104316.
    View in: PubMed
    Score: 0.475
  5. Wozniak KL, Hole CR, Yano J, Fidel PL, Wormley FL. Characterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection. Microbiology (Reading). 2014 Jul; 160(Pt 7):1440-1452.
    View in: PubMed
    Score: 0.465
  6. Chaturvedi AK, Weintraub ST, Lopez-Ribot JL, Wormley FL. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses. Proteomics. 2013 Dec; 13(23-24):3429-41.
    View in: PubMed
    Score: 0.452
  7. Chaturvedi AK, Wormley FL. Cryptococcus antigens and immune responses: implications for a vaccine. Expert Rev Vaccines. 2013 Nov; 12(11):1261-72.
    View in: PubMed
    Score: 0.450
  8. Wozniak KL, Kolls JK, Wormley FL. Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by ?d T cells. BMC Immunol. 2012 Dec 07; 13:65.
    View in: PubMed
    Score: 0.423
  9. Hardison SE, Herrera G, Young ML, Hole CR, Wozniak KL, Wormley FL. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J Immunol. 2012 Oct 15; 189(8):4060-8.
    View in: PubMed
    Score: 0.416
  10. Walraven CJ, Gerstein W, Hardison SE, Wormley F, Lockhart SR, Harris JR, Fothergill A, Wickes B, Gober-Wilcox J, Massie L, Ku TS, Firacative C, Meyer W, Lee SA. Fatal disseminated Cryptococcus gattii infection in New Mexico. PLoS One. 2011; 6(12):e28625.
    View in: PubMed
    Score: 0.395
  11. Wozniak KL, Hardison S, Olszewski M, Wormley FL. Induction of protective immunity against cryptococcosis. Mycopathologia. 2012 Jun; 173(5-6):387-94.
    View in: PubMed
    Score: 0.394
  12. Wozniak KL, Young ML, Wormley FL. Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vaccine Immunol. 2011 May; 18(5):717-23.
    View in: PubMed
    Score: 0.376
  13. Wozniak KL, Hardison SE, Kolls JK, Wormley FL. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One. 2011 Feb 17; 6(2):e17204.
    View in: PubMed
    Score: 0.373
  14. Hardison SE, Wozniak KL, Kolls JK, Wormley FL. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection. Infect Immun. 2010 Dec; 78(12):5341-51.
    View in: PubMed
    Score: 0.363
  15. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Wormley FL. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am J Pathol. 2010 Feb; 176(2):774-85.
    View in: PubMed
    Score: 0.345
  16. Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, Wormley FL. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One. 2009 Sep 03; 4(9):e6854.
    View in: PubMed
    Score: 0.337
  17. Young M, Macias S, Thomas D, Wormley FL. A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins. Proteomics. 2009 May; 9(9):2578-88.
    View in: PubMed
    Score: 0.329
  18. Wormley FL, Perfect JR, Steele C, Cox GM. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain. Infect Immun. 2007 Mar; 75(3):1453-62.
    View in: PubMed
    Score: 0.280
  19. Wormley FL, Cox GM, Perfect JR. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain. Microb Pathog. 2005 Feb-Mar; 38(2-3):113-23.
    View in: PubMed
    Score: 0.245
  20. Wormley FL, Perfect JR. Immunology of infection caused by Cryptococcus neoformans. Methods Mol Med. 2005; 118:193-8.
    View in: PubMed
    Score: 0.244
  21. Zhai B, Wozniak KL, Masso-Silva J, Upadhyay S, Hole C, Rivera A, Wormley FL, Lin X. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants. mBio. 2015 Oct 06; 6(5):e01433-15.
    View in: PubMed
    Score: 0.129
  22. Eastman AJ, He X, Qiu Y, Davis MJ, Vedula P, Lyons DM, Park YD, Hardison SE, Malachowski AN, Osterholzer JJ, Wormley FL, Williamson PR, Olszewski MA. Cryptococcal heat shock protein 70 homolog Ssa1 contributes to pulmonary expansion of Cryptococcus neoformans during the afferent phase of the immune response by promoting macrophage M2 polarization. J Immunol. 2015 Jun 15; 194(12):5999-6010.
    View in: PubMed
    Score: 0.125
  23. Wormley FL, Heinrich G, Miller JL, Perfect JR, Cox GM. Identification and characterization of an SKN7 homologue in Cryptococcus neoformans. Infect Immun. 2005 Aug; 73(8):5022-30.
    View in: PubMed
    Score: 0.063
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support